Overview
Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma
Status:
Completed
Completed
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as G-CSF may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. It is not yet known whether chemotherapy and surgery plus G-CSF is more effective than chemotherapy and surgery alone in treating patients with osteosarcoma. PURPOSE: Randomized phase III trial to compare the effectiveness combination chemotherapy and surgery with or without G-CSF in treating patients who have newly diagnosed osteosarcoma.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTCCollaborator:
Medical Research CouncilTreatments:
Doxorubicin
Lenograstim
Liposomal doxorubicin
Criteria
DISEASE CHARACTERISTICS:- Histologically proven resectable osteosarcoma of the long bone of an extremity
- No parosteal (juxtacortical), periosteal, Pagetoid, or post-irradiation sarcoma
- No distant metastases
PATIENT CHARACTERISTICS:
Age:
- 40 and under
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Neutrophil count at least 1,500/mm^3 OR
- WBC at least 3,500/mm^3
- Platelet count at least 100,000/mm^3
Hepatic:
- Bilirubin no greater than 1.2 mg/dL
Renal:
- Glomerular filtration rate at least 60 mL/min
Cardiovascular:
- No history of cardiac dysfunction
Other:
- No other prior or concurrent malignancy except basal cell skin cancer OR
- Carcinoma in situ of the cervix
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- Not specified
Chemotherapy:
- No other concurrent chemotherapy
Endocrine therapy:
- Not specified
Radiotherapy:
- See Disease Characteristics
Surgery:
- See Disease Characteristics
Other:
- No prior therapy